Estimations des analystes de Wall Street pour Maravai LifeSciences Holdings, Inc. (MRVI): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-05 | $-0.06 | ||
| 2026-08-06 | $-0.02 | $-0.04 | +54.1% |
| 2026-05-07 | $0.01 | $-0.05 | +120.0% |
| 2026-02-25 | $-0.04 | $-0.07 | +42.9% |
| 2025-11-06 | $-0.08 | $-0.06 | -33.3% |
| 2025-08-11 | $-0.08 | $-0.06 | -33.3% |
| 2025-05-12 | $-0.08 | $-0.07 | -14.3% |
| 2025-03-18 | $-0.06 | $-0.03 | -100.0% |
Ratios de valorisation
| Prix / Valeur comptable | 4.74 |
| EV / EBITDA | -4.87 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenus | $123.8M | $143.1M | $284.1M | $799.2M | $883.0M | $288.9M | $259.2M | $185.7M |
| Coût des Ventes | $60.8M | $66.8M | $79.6M | $140.6M | $169.0M | $148.7M | $150.9M | $152.4M |
| Marge Brute | $63.1M | $76.3M | $204.4M | $658.7M | $714.0M | $140.2M | $108.3M | $33.4M |
| R&D | $4.5M | $3.6M | $9.3M | $15.2M | $18.4M | $17.3M | $19.2M | $23.3M |
| Frais Généraux | $41.2M | $48.4M | $94.2M | $100.1M | $129.3M | $151.4M | $161.8M | $171.5M |
| Charges Opérationnelles | $45.7M | $52.3M | $84.5M | $104.0M | $139.8M | $171.8M | $343.9M | $40.1M |
| Résultat Opérationnel | $16.4M | $24.0M | $119.9M | $554.6M | $574.2M | -$31.6M | -$235.6M | -$6.7M |
| EBITDA | $33.2M | $48.2M | $138.3M | $585.8M | $610.0M | $712.4M | -$156.9M | -$147.1M |
| Charges d'Intérêt | $27.4M | $30.0M | $30.7M | $30.3M | $20.4M | $45.9M | $47.7M | $27.0M |
| Résultat Avant Impôts | -$16.5M | -$5.9M | $81.7M | $530.8M | $551.5M | $617.7M | -$261.5M | -$235.0M |
| Impôts | $417000 | -$652000 | $2.9M | $61.5M | $60.8M | $756.1M | -$1.9M | -$4.2M |
| Résultat Net | -$17.7M | -$8.5M | $76.9M | $182.0M | $220.2M | -$119.0M | -$144.8M | -$130.8M |
| BPA | $-0.20 | $-0.05 | $7.43 | $1.59 | $1.67 | $-0.90 | $-1.05 | $-0.91 |
| BPA Dilué | $-0.20 | $-0.05 | $2.36 | $1.56 | $1.67 | $-0.90 | $-1.05 | $-0.91 |
| Actions en Circulation (Diluées) | $89.0M | $96.6M | $96.6M | $122.0M | $131.7M | $131.9M | $137.9M | $145.1M |
Prix
| Prix | $6.84 |
| Capitalisation | $1.9B |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: BCAX · DNA · IOVA · KURA · LENZ · PRME · REPL
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de MRVI: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions